BRIEF

on AMOEBA (EPA:ALMIB)

Amoéba signs a strategic agreement with Metron Technology in China

Stock price chart of AMOEBA (EPA:ALMIB) showing fluctuations.

Amoéba, a French greentech company, has formalized an agreement with Metron Technology, a subsidiary of the Oriental Beauty Valley (OBV) group, to promote its cosmetic ingredient in China. This agreement, detailed in a memorandum of understanding dated April 2025, addresses regulatory and commercial aspects. Oriental Beauty Valley will support Amoéba in obtaining approval for this essential ingredient in China, and Metron Technology will play a key role in its distribution in China.

In 2024, Amoéba added its ingredient to the INCI list, allowing for global marketing, except in China. The Chinese market represents a key opportunity for the company, as it is the world's second-largest cosmetics market. The agreement with OBV therefore marks a major step forward in Amoéba's ambition to expand its influence in the international cosmetics sector.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all AMOEBA news